case_images: PMC6352632_01
case_images: Pelvic ultrasound showing a big uterine mass with inhomogeneous echogenicity
case_images: IJNM-34-60-g001.jpg
case_images: PMC6352632_01_IJNM-34-60-g001.jpg
case_images: F1
case_images: Ultrasounds examinations revealed a big solid mass in the cervix with an inhomogeneous echogenicity and no evidence of significant ovarian alterations [Figure 1].
case_images: Positron emission tomography/computerized tomography sagittal scan showing a big hypermetabolic uterine mass (yellow arrow) with maximum standardized uptake value 16.2 g/ml bw
case_images: IJNM-34-60-g002.jpg
case_images: PMC6352632_01_IJNM-34-60-g002.jpg
case_images: F2
case_images: The images showed an uterine mass extended from fundus to cervix (longitudinal diameter 58 mm and axial diameter 64 mm), with a high uptake of 18[F] FDG (maximum standardized uptake value [SUVmax]) 16.2 g/ml bw, metabolic volume tumor 17 cm3) [Figure 2].
case_images: Axial and sagittal computerized tomography scan showing contrast enhancement in the uterine mass
case_images: IJNM-34-60-g003.jpg
case_images: PMC6352632_01_IJNM-34-60-g003.jpg
case_images: F3
case_images: The mass also showed contrast enhancement after iodinate contrast administration [Figure 3].
case_images: Positron emission tomography, computerized tomography with iodinated contrast and positron emission tomography/computerized tomography axial scans showing the involvement of the right ovary (orange arrows)
case_images: IJNM-34-60-g004.jpg
case_images: PMC6352632_01_IJNM-34-60-g004.jpg
case_images: F4
case_images: Moreover, the right ovary presented a moderate enlargement (40 mm x 23 mm) and a big uptake of the radiopharmaceutical (SUVmax 7.7 g/ml bw) [Figure 4].